Factor XIII Val34Leu polymorphism and γ-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 9, 2005, Pages 2015-2021

  Undas, A ^a   Brzezinska Kolarz, B ^a   Brummel Ziedins, K ^b   Musial, J ^a   Szczeklik, A ^a   Mann, Kenneth G ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Cross linking; Factor XIII; Fibrin; Oral anticoagulation

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 13; DIMER; FIBRINOGEN; LEUCINE; VALINE; WARFARIN;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME POLYMORPHISM; FEMALE; HUMAN; IMMUNOBLOTTING; IN VIVO STUDY; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; ANTICOAGULANTS; FACTOR XIII; FEMALE; FIBRIN; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PROTEIN SUBUNITS; WARFARIN;

EID: 30644464285     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01509.x     Document Type: Article

References (29)

1. Blombäck B. Fibrinogen and fibrin - proteins with complex roles in haemostasis and thrombosis. Thromb Res 1996; 83: 1-75.
2. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 11-30.
3. Muszbek L, Yee LC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999; 94: 271-305.
4. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100: 743-54.
5. Tamaki T, Aoki N. Cross-linking of alpha 2 plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta 1981; 66: 280-6.
6. Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem 1999; 274: 22862-70.
7. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
8. Mikkola H, Syrjala M, Rasi V, Vahtera E, Hamalainen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-25.
9. Elbaz A, Poirier O, Canaple S, Chedru F, Cambien F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
10. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
11. Van Hylckama Vlieg A, Komanasin N, Ariëns RAS, Poort SR, Grant PJ, Bertina RM, Rosendaal FR. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep vein thrombosis. Br J Haematol 2002; 119: 169-75.
12. Corral J, Gonzalez-Conejero R, Iniesta JA, Rivera J, Martinez C, Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000; 85: 293-7.
13. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ. Factor XIII Val34Leu: a novel association with primary intracerebral hemorrhage. Stroke 1998; 29: 813-6.
14. Undas A, Sydor WJ, Brummel K, Musial J, Mann KG, Szczeklik A. Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism. Circulation 2003; 107: 17-20.
15. Wartiovaara U, Mikkola H, Szôke G, Haramura G, Kárpá ti L, Balogh I, Lassila R, Muszbek L, Paolotie A. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 2000; 84: 595-600.
16. Ariëns RAS, Phillipou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96: 988-95.
17. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood 2001; 98: 2423-31.
18. Weiss JH, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71: 629-35.
19. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A. Simvastatin impairs blood coagulation by inhibiting activation of prothrombin, factor V, factor XIII, and by enhancing factor Va inactivation. Circulation 2001; 103: 2248-53.
20. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-45.
21. Balogh I, Szôke G, Kárpáti L, Wartiovaara U, Katona E, Komaromi I, Haramura G, Pfliegler G, Mikkola H, Muszbek L. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-86.
22. Murthy SNP, Wilson J, Guy SL, Lorand L. Intramolecular crosslinking of monomeric fibrinogen by tissue transglutaminase. Proc Natl Acad Sci U S A 1991; 88: 10601-4.
23. Selmayer E, Mahn I, Muller-Berghaus G. Crosslinking of soluble fibrin and fibrinogen. Thromb Res 1985; 39: 467-74.
24. Murthy SNP, Lorand L. Cross-linked Aα·γ chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase. Proc Natl Acad Sci U S A 1990; 87: 9679-82.
25. Shainoff JR, Valenzuela R, Urbanic DA, DiBello PM, Lucas FV, Graor R. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease. Blood Coagul Fibrinolysis 1990; 1: 499-503.
26. Gerner C, Steinkellner W, Holzmann K, Gsur A, Grimm R, Ensinger C, Obrist P, Sauermann G. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis. Thromb Haemost 2001; 85: 494-501.
27. Kyrle PA, Brockmeier J, Weltermann A, Eichinger S, Speiser W, Lechner K, Eichler H-G. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment. Thromb Haemost 1997; 77: 685-9.
28. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991; 5: 3071-7.
29. Murthy SNP, Wilson JH, Lukas TJ, Veklich Y, Weisel JW, Lorand L. Transglutaminase-catalyzed crosslinking of the Aα- and γ-constituent chains in fibrinogen. Proc Natl Acad Sci U S A 2000; 97: 44-8.